1. Home
  2. HLIT vs CSTL Comparison

HLIT vs CSTL Comparison

Compare HLIT & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmonic Inc.

HLIT

Harmonic Inc.

HOLD

Current Price

$9.32

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$39.47

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLIT
CSTL
Founded
1988
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
HLIT
CSTL
Price
$9.32
$39.47
Analyst Decision
Buy
Strong Buy
Analyst Count
5
6
Target Price
$13.13
$43.17
AVG Volume (30 Days)
1.1M
351.9K
Earning Date
02-09-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.43
N/A
Revenue
$635,710,000.00
$343,530,000.00
Revenue This Year
N/A
$1.69
Revenue Next Year
$21.77
N/A
P/E Ratio
$22.58
N/A
Revenue Growth
1.93
10.15
52 Week Low
$7.80
$14.59
52 Week High
$13.41
$42.18

Technical Indicators

Market Signals
Indicator
HLIT
CSTL
Relative Strength Index (RSI) 33.10 52.97
Support Level $9.84 $37.29
Resistance Level $10.20 $41.35
Average True Range (ATR) 0.25 1.35
MACD -0.07 -0.27
Stochastic Oscillator 0.00 36.13

Price Performance

Historical Comparison
HLIT
CSTL

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: